Published in Lab Business Week, April 30th, 2006
This latest round was led by Prism Venture Partners and joined by Baird Venture Partners, both new investors. Existing investors U.S. Venture Partners and Pequot Ventures also participated in this round.
Aptus Endosystems will use the proceeds to support continuing development activities, initiate the U.S. clinical trial program, STAPLE-1, for its Abdominal Aortic Aneurysm (AAA) product; and build its operations infrastructure.
"We are pleased to...
Want to see the full article?
Welcome to NewsRx!
Learn more about a six-week, no-risk free trial of Lab Business Week